Matthew L. Posard Insider Trading $TLIS Talis Biomedical Corp
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew L. Posard.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew L. Posard. Matthew L. Posard is Sr VP & General Manager in ILLUMINA INC ($ILMN) and Sr VP & GM, Consumer Genomics in ILLUMINA INC ($ILMN) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and Chief Commercial Officer in Trovagene, Inc. ($XNOM.OB) and Director in Talis Biomedical Corp ($TLIS) and Director in DermTech, Inc. ($DMTK).
Matthew L. Posard in Talis Biomedical Corp
Trading Symbol: TLISIndustry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Matthew L. Posard: Director
Holdings: 62,500 shares
Latest Transaction: Feb 19 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Matthew L. Posard in Talis Biomedical Corp
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XNOM.OB, DMTK, GYHT, ILMN, TLIS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 19 2021 | TLIS | Talis Biomedical C ... | Posard Matthew L. | Director | Buy | P | 16.00 | 62,500 | 1,000,000 | 62,500 | 0 to 62.5 K |
Page: 1